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Background: Resilient adaptation can be construed in different ways, but as used here it
refers to adaptive brain responses associated with avoidance of psychopathology despite
expressed genetic predisposition to Bipolar Disorder (BD). Although family history of
BD is associated with elevated risk of affective morbidity a significant proportion of
first-degree relatives remain free of psychopathology. Examination of brain structure
and function in these individuals may inform on adaptive responses that pre-empt
disease expression. Methods: Data presented here are derived from the Vulnerability
to Bipolar Disorders Study (VIBES) which includes BD patients, asymptomatic relatives
and controls. Participants underwent extensive investigations including brain structural
(sMRI) and functional magnetic resonance imaging (fMRI). We present results from sMRI
voxel-based-morphometry and from conventional and connectivity analyses of fMRI data
obtained during the Stroop Colour Word Test (SCWT), a task of cognitive control during
conflict resolution. All analyses were implemented using Statistical Parametric Mapping
software version 5 (SPM5). Resilience in relatives was operationalized as the lifetime
absence of clinical-range symptoms. Results: Resilient relatives of BD patients expressed
structural, functional, and connectivity changes reflecting the effect of genetic risk on the
brain. These included increased insular volume, decreased activation within the posterior
and inferior parietal regions involved in selective attention during the SCWT, and reduced
fronto-insular and fronto-cingulate connectivity. Resilience was associated with increased
cerebellar vermal volume and enhanced functional coupling between the dorsal and
the ventral prefrontal cortex during the SCWT. Conclusions: Our findings suggests the
presence of biological mechanisms associated with resilient adaptation of brain networks
and pave the way for the identification of outcome-specific trajectories given a bipolar
genotype.
Keywords: MRI, bipolar disorder, connectivity, predisposition, risk, resilience
INTRODUCTION
Bipolar Disorder (BD) is characterized by mood dysregulation
manifesting as recurrent episodes of depression and mania with
variable inter-episode remission (APA, 1994). Genetic factors are
known to contribute between 60% and 85% to the liability to
BD (McGuffin et al., 2003; Lichtenstein et al., 2009). However,
the pathway leading from genetic risk to clinical phenotype is
complex and not clearly mapped. Recent genome-wide associ-
ation studies have identified a number of risk conferring loci
(Ferreira et al., 2008; Sklar et al., 2011). These however, explain
only a small fraction of the heritability to BD. Genetic proximity
to affected individuals remains the single most significant pre-
dictor of disease expression as first-degree relatives of patients
show a 10-fold increase in their relative risk for BD (Smoller
and Finn, 2003). This observation often obscures the fact that
the majority (approximately 60%) of first-degree relatives of BD
patients remain free of psychiatric pathology (Mowbray et al.,
2006). Consequently research to date has focused nearly exclu-
sively on risk-increasing factors without similar attention being
directed to factors associated with resilience. This paper attempts
to address this issue within the framework of resilient adaptation.
Resilient adaptation can be construed in different ways, but
as used here it refers to adaptive brain features associated with
avoidance of psychopathology despite expressed genetic predis-
position to BD. There are several considerations that led us to
this particular formulation. Firstly, we employed an operational
definition of resilience (Carpenter et al., 2001) predicated on
the lifetime absence of “adverse” clinical outcomes (i.e., clinical-
range symptoms). There is substantial evidence of an association
between genetic risk for BD and changes in cognition (Arts
et al., 2008; Bora et al., 2009; Glahn et al., 2010), brain structure
(McDonald et al., 2004; McIntosh et al., 2004) and brain function
(Drapier et al., 2008; Thermenos et al., 2010). Abnormalities in
these measures could also be considered as “adverse” outcomes.
However, we chose to define outcome using clinical symptoms
only since our primary concern is to determine the correlates
of resilience to overt disease expression. Secondly, the variance
in risk among first-degree relatives of BD patients is expected
be a large. Moreover, it is currently not possible to define the
specific risk factors that comprise each individual’s genetic pre-
disposition. Here we follow the convention of using genetic
proximity to an affected individual as a measure of “genetic”
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burden. Despite encompassing individuals with variable genetic
liability this approach has been successfully employed in nearly
all studies that have examined the impact of genetic risk for BD
(e.g., McDonald et al., 2004; McIntosh et al., 2004; Arts et al.,
2008; Drapier et al., 2008; Thermenos et al., 2010). Thirdly, an
added difficulty arises when considering the potential contribu-
tion of shared “non-genetic” factors to disease liability amongst
family members. To minimize the effects of shared environment
the unaffected family members sampled here were unrelated to
each other. Fourthly, resilience is likely to arise from adaptive
responses at multiple levels ranging from cellular (Hunsberger
et al., 2009) to psychological (Galvez et al., 2011). Here we focus
exclusively on the brain structural and functional correlates of
resilience as assessed with MRI. As BD is thought to arise from
disruptive changes in brain systems (Phillips et al., 2008) the ques-
tion is whether adaptive changes may promote resilience. Fifthly,
our definition requires the presence of brain structural and func-
tional deviance in relatives indicative of expressed genetic pre-
disposition as a means of distinguishing between apparent and
true resilience. Apparent resilience may be a consequence of low
genetic “burden” in which case disruption to brain systems in
healthy relatives would be expected to be minimal. The presence
of brain structural and functional abnormalities that are common
in healthy relatives and in BD patients is considered as evidence of
expressed shared genetic predisposition. Obviously, such abnor-
malities define a state of vulnerability to BD but are not sufficient
for disease expression. Sixthly, brain structural and functional
features that differentiate healthy relatives from BD patients and
controls are considered as adaptive responses to abnormalities
related to genetic predisposition. Seventhly, the diagnostic sta-
tus of healthy relatives has the potential to change. Apparent
resilience may be a function of the timing and length of the period
of observation. The peak age of onset of BD is between 16 and
30 years (Merikangas et al., 2011). The majority of individuals
who develop BD will do so before aged 25 years (Merikangas
et al., 2011) whereas the conversion rate thereafter is very low
(Akiskal et al., 1995; Coryell et al., 1995). Consequently we sam-
pled healthy relatives that had passed through the highest period
of risk for developing BD.
With these considerations in mind we examined the brain
structural and functional correlates of resilience in healthy first-
degree relatives of patients with BD derived from the Vulnerability
to Bipolar Disorders Study (VIBES) (Frangou, 2009). The func-
tional paradigm employed was the Stroop Colour Word Test
(SCWT) (Stroop, 1935), considered a prototypical task of cogni-
tive control during conflict resolution. The SCWT tests the ability
to overcome interference from competing sensory information
(selective attention) and, in parallel, to choose the appropriate
response amongst conflicting alternatives (inhibitory control).
Disruption in these processes may be central to the pathophysiol-
ogy of BD since distractibility and disinhibition are core diagnos-
tic symptoms of mania (APA, 1994). Additionally, neurocognitive
studies have reliably shown that abnormalities in selective atten-
tion and inhibitory control persist in remitted patients (Arts et al.,
2008; Bora et al., 2009; Stefanopoulou et al., 2009).
Versions of the SCWT have been successfully used in func-
tional magnetic resonance imaging (fMRI) studies to highlight
deficits in BD, particularly within the ventrolateral prefrontal cor-
tex (VLPFC) (Blumberg et al., 2003; Gruber et al., 2004; Malhi
et al., 2005; Kronhaus et al., 2006; Roth et al., 2006; Lagopoulos
and Malhi, 2007; Pavuluri et al., 2008; Chen et al., 2011; Pompei
et al., 2011a,b). Additional functional deficits in patients with BD
during this task have been noted in the dorsolateral prefrontal
cortex (DLPFC), (Kronhaus et al., 2006; Lagopoulos and Malhi,
2007), the anterior cingulate cortex (ACC) (Strakowski et al.,
2005; Roth et al., 2006) and in subcortical regions (Blumberg
et al., 2003; Malhi et al., 2005; Strakowski et al., 2005).
We tested the following hypotheses: (a) healthy relatives and
BD patients will share brain structural and functional features
that will differentiate both groups from controls. These biologi-
cal features will be considered as expressed genetic predisposition
to BD, (b) healthy relatives will manifest brain structural and
functional features differentiating them from BD patients and
controls. These biological features will be considered as adaptive
responses associated with resilience, and (c) BD patients will show
brain structural and functional changes differentiating them from
healthy relatives and controls. These changes will be considered
as correlates of disease expression. The value of this approach is
threefold: (a) it enables disambiguation between biological alter-
ations relating to genetic risk for BD that may be necessary but
not sufficient for the development of overt clinical symptoms,
(b) it focuses attention on dynamic biological processes engaged
in overcoming genetic predisposition to BD, and (c) it has the
potential to identify mechanisms that offer new insights for the
prevention or treatment of BD.
MATERIALS AND METHODS
PARTICIPANTS
All participants (Table 1) derived from the VIBES study sam-
ple (Frangou, 2009; Kempton et al., 2009; Walterfang et al.,
2009; Takahashi et al., 2010; Jogia et al., 2011; Lelli-Chiesa et al.,
2011; Perrier et al., 2011; Pompei et al., 2011a,b). Patients ful-
filled criteria for BD type I according to the Diagnostic and
Statistical Manual of Mental Disorders, 4th edition, revised
(DSM-IV) (APA, 1994), had no comorbid psychiatric disorders
and no family history (up to second-degree) of schizophrenia or
schizophrenia spectrum disorders. Siblings and offspring with-
out a personal history of Bipolar Spectrum Disorders were also
invited to participate. Healthy controls without a personal or fam-
ily history of any Axis I DSM-IV disorders were selected to match
Table 1 | VIBES sample: clinical and demographic characteristics.
Bipolar patients Relatives Controls
(n = 47) (n = 48) (n = 71)
Age 46.2 (11.5) 36.5 (13.8) 39.8 (15.3)
Gender (female/male) 26/21 25/25 35/36
IQ 118.7 (17.7) 117.8 (16.8) 121.5 (19.3)
Age of onset 25.5 (8.2) N/A N/A
Illness duration 20.0 (9.1) N/A N/A
HDRS 3.0 (3.9) 0.0 (0.3) (0.2) (0.5)
YMRS 1.3 (2.9) 0.0 (0) (0.2) (0.5)
BPRS 26.9 (3.5) 24.0 (0.3) 24.4 (0.6)
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patients and relatives in age, sex, and educational level. All par-
ticipants were screened to exclude past, current, and hereditary
neurological disorders, DSM-IV lifetime substance dependence
or abuse in the preceding six months and contraindications to
MR imaging.
ASSESSMENTS
All participants underwent detailed interview and assessment.
Diagnostic status was ascertained using the Structured Clinical
Interview for DSM-IV for Axis I (First et al., 2002a,b) and Axis II
diagnoses (First et al., 1997). Family history of psychiatric dis-
orders was ascertained using the Family Interview for Genetic
Studies (Maxwell, 1992). Symptoms were evaluated with the
Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960),
the Young Mania Rating Scale (YMRS) (Young et al., 1978) and
the Brief Psychiatric Rating Scale (BPRS) (Lukoff et al., 1986).
The intelligence quotient (IQ) derived from the Wechsler Adult
Intelligence Scale-Revised (WAIS-R) (Wechsler, 1997) was used
as a measure of general intellectual ability. Handedness was based
on self-report. Prior to scanning BD patients were assessed weekly
over a minimum period of one month to ensure that at each eval-
uation they (a) scored below seven in the HDRS and YMRS and
(b) there had been no change to their medication status.
There were no differences between groups in sex (p = 0.95),
age (p = 0.23), and IQ (p = 0.52). Although the level of symp-
tomatology was very low in all groups (Table 1), BD patients had
higher HDRS, YMRS, and BPRS scores compared to all other
groups (all p < 0.003) while there was no difference between
relatives and controls (all p > 0.80).
None of the relatives was on prescribed medication. Thirty-
nine BD patients were on psychotropic medication; 17 on
antipsychotics (12 on atypical, two on typical and three on both),
30 on mood stabilizers (17 on lithium, four on lamotrigine, three
on carbamazepine and 10 on sodium valproate), and 13 on selec-
tive serotonin reuptake inhibitors. None received anticholinergic
or benzodiazepines. The comparable daily dose was calculated
for current antipsychotic use when relevant (Bezchlibnyk-Butler
and Jeffries, 2000). Unmedicated BD patients had discontinued
medication of their own accord for an average of six months.
Medicated and unmedicated BD patients did not differ in age
of onset, illness duration, IQ, HDRS, and YMRS total scores (all
p > 0.31).
NEUROIMAGING
Both anatomical and functional imaging data were acquired dur-
ing the same session using a 1.5T GE Neuro-optimized Signa
Magnetic resonance (MR) system (General Electric, Milwaukee,
WI) based at theMaudsleyHospital, London. All images were first
checked for gross structural anomalies and were then processed
and analyzed using Statistical Parametric Mapping software
version 5 (SPM5) (www.fil.ion.ucl.ac.uk/spm/software/spm5)
in a Matlab environment (Version 7, The Mathworks Inc,
Natick, MA).
Structural MRI
Anatomical images were acquired in the axial plane using
a T1-weighted, three-dimensional (3D) 3D inversion recov-
ery prepared spoiled gradient recalled protocol [echo time
(TE) = 5.1ms, repetition time (TR) = 1800ms, inversion time
= 450ms, flip angle = 20◦, slice thickness = 1.5mm, in plane
resolution = 0.9375 × 0.9375mm, matrix size = 256 × 192, field
of view = 40 × 180mm, number of excitations = 1].
We implemented voxel-based morphometry (VBM) using
unified segmentation in SPM. Images were transformed into stan-
dard stereotactic Montreal Neurological Institute (MNI) space
and smoothed using a Gaussian isotropic kernel of 12mm full
width half maximum (FWHM). The gray, white, and CSF frac-
tions of the modulated images were summed to produce an
estimate of total intracranial volume (TIV). There was no sig-
nificant difference in mean TIV between the groups (p = 0.15).
The mean TIV of the relatives was higher by 3.6% and 4.5%,
respectively, compared to that of controls and BD patients, and
therefore, TIV was included as a covariate in an analysis of covari-
ance (ANCOVA) model in SPM to examine the effect of group
(BD patients, relatives, controls) on regional gray matter vol-
ume. The threshold for statistical significance was set at p <
0.001 (uncorrected) (Thirion et al., 2007) with a cluster thresh-
old of = 5. We used MarsBaR (www.marsbar.sourceforge.net) to
extract gray matter volumes from each subject from suprathresh-
old regions for further analyses implemented in SPSS 15.0 (SPSS
Inc., Chicago, IL, USA) to examine the effect of medication.
Functional MRI
The SCWT was administered over six minutes using a block
design incorporating alternating neutral (control) and interfer-
ence (active) conditions. In the interference condition, stimuli
were single color words (YELLOW, GREEN, RED, and BLUE)
displayed in an incongruent font color (e.g., “GREEN” displayed
in red font color). In the neutral condition a string of four Xs
was displayed in one of the four font colors. There were five
blocks of each condition, with 10 stimuli per block. Each stim-
ulus was presented on a black background (duration 100ms),
preceded by a fixation cross (duration 1500ms) and followed by a
blank screen (duration 2100ms). Participants were instructed to
ignore the word referent and name the font color. Their responses
were recorded using voice activated software. Performance was
evaluated in terms of response time and accuracy (% correct
responses).
A total of 104 T2∗-weighted echo planar imaging brain vol-
umes depicting blood-oxygenation level-dependent (BOLD) con-
trast were acquired at each of 18 non-contiguous axial planes
(TE = 40ms, actual TR = 3500ms, voxel dimensions = 3.75
× 3.75 × 7mm, interslice gap = 0.7mm, matrix size = 64 ×
64, flip angle = 90◦). Images were realigned, transformed into
MNI space, and smoothed with an isotropic Gaussian kernel of
8mm FWHM. Registration parameters were extracted and com-
pared between groups. The first-level analysis was performed by
modeling the fMRI responses using a canonical hemodynamic
response function (HRF) convolved with the vectors of interest.
We analyzed the data using a general linear model with the fol-
lowing vectors of onset as explanatory variables: correct responses
in the incongruent condition, correct responses in the neutral
condition, incorrect responses (errors of commission or omis-
sion). By modeling out errors, we focused on successful trials.
Six movement parameter vectors (translation x, y, z, and rotation
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x, y, z) generated from the realignment procedure were also
modeled as regressors of no interest. The model additionally
included drift terms up to 1/128Hz to remove low-frequency
components, and global confounds were removed using global
normalization. Contrast images representing the incongruent
minus neutral condition were produced for each subject. Full fac-
torial analysis using a random-effects model was conducted to
examine the effect of group with total BPRS score and age as
covariates. Suprathreshold clusters were identified using a False
Discovery Rate (FDR) correction of p < 0.05. Weighted param-
eter estimates were extracted from each suprathreshold cluster
and used in further analyses implemented in SPSS 15.0 (SPSS
Inc., Chicago, IL, USA) to examine the effect of medication and
relationship to performance.
Both for structural and functional MRI analyses stereo-
tactic coordinates were converted from MNI spatial array
to that of Talairach and Tournoux (www.mrc-cbu.cam.ac.uk/
Imaging/mnispace.html) and corresponding Brodmann areas
(BA) were identified with the Talairach Daemon Client
(www.talairach.org).
Functional connectivity analysis
Functional connectivity analysis was performed using
Psychophysiological Interaction (PPI) (Friston et al., 1997)
implemented in SPM5 and focused on the connectivity of the
VLPFC (seed region) during the SCWT. The design matrix com-
prised three regressors: the “psychological variable,” representing
the experimental task (SCWT), the “physiological variable,”
representing the signal time course in the seed region, and a
variable representing their interaction. In each individual the
seed point was localized in native space based on the coordinates
for the right VLPFC from the factorial group contrast for the
incongruent > neutral condition. A region of interest (ROI)
was extracted from a sphere of 2mm radius around the group
maxima within the same anatomical area defined by the PickAtlas
toolbox (Maldjian et al., 2003), and thresholded at p < 0.05
uncorrected to ensure its presence in all subjects. A variable
representing the interaction between each time series and the
psychological variable (incongruent condition vs. neutral condi-
tion) was constructed for each subject. Voxel-wise PPI analysis
was conducted within each group separately. Subject-specific
contrast images were then entered into a random-effects analysis
using one-sample t-tests (thresholded at p < 0.0001 voxel-wise
with p < 0.05 cluster level correction). Group differences (BD
patients, relatives, controls) in functional connectivity we
examined the interaction between the PPI (interaction between
VLPFC activity and SCWT) and group (thresholded at p < 0.001
voxel-wise). No effect of medication was detected in in PPI
analyses conducted BD patients.
RESULTS
STRUCTURAL MRI
BD patients and relatives showed similar structural changes in the
left insula (BA13) (x = 44, y = 40, z = 19, Z-score = 3.40, clus-
ter size = 17). Mean insula volume was significantly greater in
BD patients (p = 0.008) and in relatives (p = 0.013) compared
to controls (Figure 1). However, the volume of the vermis was
uniquely increased in relatives compared to BD patients (p =
0.005) and controls (all p = 0.004) (Figure 1).
FUNCTIONAL MRI
In the neutral and interference conditions controls’ accuracy and
reaction time were, respectively, 94.22 (8.90) and 0.51 s (0.28) and
92.66 (9.96) and 0.76 (0.43). Patients had an accuracy of 93.42
(9.02) and reaction time of 0.52 s (0.28) in the neutral condition
and an accuracy of 93.33 (7.58) and reaction time of 0.73 s (0.42)
in the interference condition. Relatives had an accuracy of 98.76
(6.68) and reaction time of 0.51 s (0.14) in the neutral condition
and an accuracy of 95.84 (7.35) and reaction type of 0.74 s (0.25)
in the interference condition. There was no effect of group on
accuracy (p = 0.46) or response time (p = 0.23) and no signif-
icant interactions between group and age, IQ, and BPRS score on
any measure (all p > 0.14).
Group differences in BOLD signal were observed in the supe-
rior parietal lobule (BA7) (x = 32, y = −58, z = 43, Z = 4.54,
cluster size= 290 and x = −20, y = −72, z = 44, Z = 4.41, clus-
ter size = 43), the inferior parietal lobule (BA40) (x = 34, y =
−48, z = 41, Z = 4.81, cluster size= 189 and x = −42, y = −32,
z = 50, Z = 4.60, cluster size = 20), the head of the caudate
(x = −2, y = 10, z = 1, Z = 4.31, cluster size = 19) and the
VLPFC (inferior frontal gyrus; BA47) (x = 34, y = 26, z = −8,
Z = 4.19, cluster size = 30).
In all these clusters, mean activation in BD patients was
reduced compared to that of controls (all p < 0.03). Relatives
showed deficits in parietal engagement that were comparable to
that of patients (p > 0.55) (Figure 1). However, the mean activa-
tion in the caudate and in the VLPFC in relatives was comparable
to that of controls (p > 0.24) and significantly greater than that
of BD patients (p < 0.02).
CONNECTIVITY ANALYSIS
During the SCWT controls showed significant positive interac-
tions between the right VLPFC and the left caudate nucleus and
parietal cortex. Negative interactions were found between the
right VLPFC with the insula bilaterally, with the ventral ACC
(vACC) on the left and with the globus pallidus on the rights
(Table 2). In patients with BD the connectivity of the VLPFC was
generally reduced within this network with the exception of the
insula where abnormally positive connectivity was noted. In rel-
atives, the connectivity of the VLPFC with the vACC and insula
was reduced (Figure 1). However, the coupling of the VLPFCwith
parietal and striatal regions was preserved and there was evidence
of additional connectivity between the VLPFC and the DLPFC
(Figure 1).
DISCUSSION
We hypothesized that resilient relatives of BD patients would
show unique brain structural and functional features that could
reflect adaptive responses mitigating the effect of genetic pre-
disposition. Our results suggest that resilience is associated with
increased vermal volume and greater connectivity between the
ventral and dorsal prefrontal cortex (PFC). The presence of brain
structural and functional alterations that were common in rela-
tives and patients suggests that resilience in relatives arises despite
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FIGURE 1 | Neural correlates of genetic predisposition and resilience in
relatives of bipolar patients. DLPFC = dorsolateral prefrontal cortex; CN =
caudate nucleus; GP = globus pallidus; Ins = insula; SPL = superior parietal
cortex; vACC; ventral anterior cingulate cortex; VLPFC = ventrolateral
prefrontal cortex; coordinates are presented in Talairach and Tournoux space
x = sagittal; y = coronal; z = axial.
disruption in some brain systems mediated by shared genetic
predisposition. The significance of the findings relating to genetic
predisposition and disease expression in this sample has been dis-
cussed in detail in our previous publications (Kempton et al.,
2009; Pompei et al., 2011a,b). Here we focus specifically on the
correlates of resilience and their implications for BD.
STRUCTURAL BRAIN CORRELATES OF RESILIENCE TO BD
Relatives showed an increase in the volume of the vermis com-
pared to patients and controls. This finding highlights the value
of the resilience concept in identifying the contribution of brain
regions that would not have been predicted by models of risk
for disease expression. Cerebellar involvement is not a core fea-
ture of disease expression for BD (Kempton et al., 2008, 2011).
Until recently, the cerebellum was mostly considered in terms of
its contribution to motor control. However, has become apparent
that it has a wider role in the regulation of autonomic func-
tion and cognition (Reis and Golanov, 1997; Parsons et al., 2000;
Craig, 2002; Singer et al., 2004) as well as of affective processing
(Schmahmann and Caplan, 2006). In humans, cerebellar lesions
give rise to a constellation of cognitive and affective abnormal-
ities collectively referred to as the cerebellar cognitive affective
syndrome (Schmahmann and Sherman, 1998). Based on fMRI
data a functional distinction has been drawn between the ante-
rior and posterior cerebellum; the former is more intimately
involved with higher cognitive function while the latter, including
the vermis, contributes mostly to affective regulation (Stoodley
and Schmahmann, 2009, 2010). It is thought that the posterior
cerebellum forms representation of internal affective and somatic
states and, together with cortical regions, it implements adap-
tive responses to maintain “homeostatic” control (Schmahmann,
2004; Ramnani, 2006). Accordingly increased vermal volume in
relatives could be interpreted as an adaptive response aimed at
maintaining affective equilibrium.
As previously mentioned genetic predisposition to BD was
associated with increased insular volume while increased ver-
mal volume was only observed in resilient relatives. This raises
questions as to how these two findings may relate to each other.
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Table 2 | Psychophysiological interactions with the right ventrolateral prefrontal cortex in BD patients, their relatives, and controls.
Region BA Controls Bipolar patients Relatives
Coordinates Modulation Coordinates Modulation Coordinates Modulation
(z-value) (z-value) (z-value)
Frontal Middle frontal
gyrus
9 n.s. – n.s. – −50, 29, 28
(3.63)
Positive
Anterior
cingulate
gyrus
25 −16, 5, −12
(3.15)
Negative n.s. – n.s. –
Limbic/Paralimbic Insula 13 30, 17, −1
(3.44)
Negative 34, −15, 6
(3,42)
Positive n.s. –
−32, −6, −3
(3.32)
Parietal Superior
parietal lobule
7 −28, −50, 58
(3.37)
Positive n.s – −30, −50, 52
(3.13)
Positive
Globus
pallidus
– −24, −14, −1
(3.69)
Negative n.s. – −10, 4, 2
(3.62)
Negative
Basal ganglia Caudate 10, 6, −4
(4.19)
– 20, 4, 0
(3.62)
Positive n.s. – 16, 11, 22
(3.22)
Positive
BA = Brodmann Area; coordinates are presented in Talairach and Tournoux space x = sagittal; y = coronal; z = axial; n.s. = not significant at p < 0.001 voxelwise.
Insula involvement has been shown in a variety of conditions
involving the primary and multimodal integrative processing of
interoceptive stimuli supporting both a coherent representation
and awareness of feelings toward stimuli or events (Craig, 2002,
2011). In this respect increased insular volume in BD may relate
to findings of increased conscious emotional reactivity observed
in patients (Myin-Germeys et al., 2003) and those at risk for
BD (Kwapil et al., 2011). The cerebellar vermis is not known to
have direct connections with the insula but it is involved in the
integrative processing of somatosensory stimuli (through its con-
nections with the brainstem and thalamus), emotional states (via
the amygdala, septum, and locus coeruleus) and motor responses
(through its connections with the motor cortex) (Sacchetti et al.,
2009). However, unlike the insula, the cerebellum does not influ-
ence conscious experience of emotions (Maschke et al., 2002;
Turner et al., 2007) but appears to participate in contextual emo-
tional learning and overt behavior through appropriate response
selection (Sacchetti et al., 2009). Any extrapolation from these
data to BD can only be purely speculative as this point. It could
be argued however, that resilient relatives may experience sub-
jectively greater emotional fluctuations (associated with insula
function) but their objective behavior remains appropriate due
to greater control over response selection (associated with vermal
function).
FUNCTIONAL CORRELATES OF RESILIENCE IN BD
Functional activation and connectivity in this study were exam-
ined using the SCWT. In healthy individuals the task engages
a network of brain structures with evidence of relative regional
specialization (Wager et al., 2005; Nee et al., 2007). Within this
network, the DLPFC is thought to maintain representations of
task-relevant information and to bias activity in other regions
toward task-appropriate responses (Milham et al., 2003; Liu
et al., 2006; Nee et al., 2007). Selective attention processes oper-
ating within posterior parietal regions integrate task relevance
and stimulus features into unified representations of “salience”
(Buschman andMiller, 2007) or “priority” (Bays et al., 2010) used
for competitive stimulus selection. The ACC is involved in moni-
toring conflict and performance (MacDonald et al., 2000; Milham
et al., 2003; Liu et al., 2006; Nee et al., 2007; Pochon et al., 2008).
Response execution primarily involves the VLPFC (Aron et al.,
2004; Nee et al., 2007) and the striatum (Derrfuss et al., 2005;
Chevrier et al., 2007; Nee et al., 2007; Robins et al., 2007; Li et al.,
2008; Ali et al., 2010).
During the SCWT patients with BD and their relatives demon-
strated quantitatively similar signal reduction in posterior parietal
regions. We infer from these results that in even in healthy rela-
tives genetic predisposition to BD disrupts the SCWT network
particularly in connection to selective attention processes that are
underpinned by the functional integrity of the posterior parietal
cortices. Patients showed additional signal decrements in regions
involved in response selection and execution, namely the VLPFC
and the caudate nucleus, which were not present in relatives.
As BD arises from abnormalities within neural systems, not
just regions, we also examined the functional integration of the
SCWT network. During tasks of cognitive control, such as the
SCWT, activation is increased in task-relevant brain regions and
reduced in regions involved in emotional processing (Drevets and
Raichle, 1998; Hester et al., 2004; Wager et al., 2005; Margulies
et al., 2007). Accordingly, controls showed negative functional
coupling between the VLPFC and the vACC and insula. Both
regions are known for their primary role in the monitoring
and generation of internal affective states (Reiman et al., 1997;
Damasio et al., 2000; Dolan, 2002; Phan et al., 2002). Connectivity
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between the VLPFC and these regions was abnormal in patients
and relatives, although the degree of deviance was greater in
patients. These observations imply that genetic liability to BD
is associated with inefficient resource allocation between corti-
cal and limbic/paralimbic regions. This finding has been reported
in a number of studies using different paradigms (Adler et al.,
2004; Krüger et al., 2006; Drevets et al., 2008; Thermenos et al.,
2010) and is therefore, likely to represent a task-independent
feature of BD. Furthermore, insular volume was found to be
increased in both patients and relatives in this sample. The
results of the connectivity analysis therefore, provide a direct link
between structural and functional alterations mediated by genetic
predisposition to BD.
A unique feature of the VLPFC connectivity in relatives was its
positive coupling with the DLPFC suggestive of reciprocal aug-
mentation in activity of these two regions. During the SCWT
engagement of the DLPFC involvement reflects the contribution
of this region both in selective attention and response selection
(Nee et al., 2007); furthermore, the DLPFC appears to modulate
activity in the VLPFC as a function of increased task difficulty
(Nee et al., 2007). We, therefore, interpret the increased con-
nectivity between ventral and dorsal lateral PFC in relatives as
an adaptive mechanism that allows greater conjunctive activity
within the PFC in response to functional dysregulation in other
areas of the SCWT network.
METHODOLOGICAL CONSIDERATIONS
The literature on adaptive responses associated with resilience
in relatives of patients with BD is sparse. The generalizability
of our findings would, therefore, require independent replica-
tion. However, our results resonate with those of Krüger et al.
(2006) who measured regional cerebral blood flow (rCBF) in
nine BD patients and nine healthy siblings after induction of
transient sadness. Patients and siblings had overlapping abnor-
malities in cortical activity during this task but importantly
siblings showed increased medial PFC activation that was unique
to their group. Furthermore, the functional findings in relatives
during the SCWT did not correlate with measures of perfor-
mance. This could be attributable to near ceiling performance in
the task. Another possibility is that adaptive responses may not
have a quantitative association with performance but they act to
maintain functional capacity.
IMPLICATIONS AND FUTURE DIRECTIONS
As discussed adaptive responses within brain networks emerge as
a feature of resilience in healthy relatives of BD patients. Adaptive
responses can be conceptualized in terms of neural reserve and
neural compensation (Stern, 2002). Neural reserve is thought to
represent the ability of brain networks to cope with pathology
or higher demands as a function of their increased efficiency or
plasticity or recruitment of additional neural resources. Neural
compensation refers to reallocation of processing to alternate
brain regions. Accordingly, the features associated with resilience
in relatives appear indicative of increased reserve since in the
SCWT, at least, the architecture of the network involved was simi-
lar to controls. However, a more precise formulation of the nature
of the adaptive responses associated with resilience will require
further studies.
Another issue for further examination is the relationship with
disease expression. Clinical symptoms may arise because of fail-
ure to develop or maintain adaptive changes in response to
genetically-mediated brain pathology. Alternatively, abnormali-
ties in specific brain areas may have a direct pathogenic effect that
pre-empts adaptive responses. Longitudinal studies of individuals
at high risk for BD would be informative in this respect.
A third question concerns the causes or sources of adaptive
brain responses in resilient relatives. For example, Hunsberger
et al. (2009) have proposed several mechanisms that could poten-
tially enhance resilience in BD that relate to regulation of stress
response or apoptotic cascades.
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